J. Backes

发表

Simvastatin and Amiodarone: Emergence of a Potentially Toxic Interaction

P. Howard, J. Backes, 2009 .

Modified-Policosanol Does Not Reduce Plasma Lipoproteins in Hyperlipidemic Patients When Used Alone or in Combination with Statin Therapy

C. Gibson, P. Moriarty, J. Backes, 2011, Lipids.

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

B. Wiggins, D. Hilleman, J. Backes, 2022, Pharmacotherapy.

Statins Atorvastatin : 80 mg Fluvastatin : 80 mg Lovastatin : IR tablets : 80 mg ER tablets : 60 mg Pitavastatin : 4 mg Pravastatin : 80 mg Rosuvastatin : 40 mg Simvastatin :

J. Backes, Christopher Korth, 2013 .

Comparison of Gemfibrozil and Fenofibrate in Patients with Dyslipidemic Coronary Heart Disease

Thomas L. Lenz, C. Destache, D. Hilleman, 2002, Pharmacotherapy.

Hypertriglyceridaemia unresponsive to multiple treatments

T. Dayspring, D. Hoefner, P. Moriarty, 2015, BMJ Case Reports.

Effects of once weekly rosuvastatin among patients with a prior statin intolerance.

C. Gibson, P. Moriarty, J. Backes, 2007, The American journal of cardiology.

Re: Gómez-Gerique, et al. Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. Atherosclerosis 2002;162:245-51.

P. Moriarty, J. Backes, 2003, Atherosclerosis.

Coenzyme Q10 for statin-associated myalgia.

P. Moriarty, J. Backes, Janelle F Ruisinger, 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Statin-associated muscle symptoms-Managing the highly intolerant.

C. Gibson, P. Moriarty, J. Backes, 2017, Journal of clinical lipidology.

The high-dose rosuvastatin once weekly study (the HD-ROWS).

C. Gibson, P. Moriarty, J. Backes, 2011, Journal of clinical lipidology.

Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance.

C. Gibson, P. Moriarty, J. Backes, 2009, The American journal of cardiology.

Statin Intolerance and Vitamin D Supplementation: Sunny, but a Few Clouds Remain…

P. Moriarty, Brian J. Barnes, J. Backes, 2015, North American journal of medical sciences.

Pseudohypertriglyceridemia: two cases of probable glycerol kinase deficiency.

T. Dayspring, P. Moriarty, J. Backes, 2012, Journal of clinical lipidology.

Quality of diabetes care for adults with developmental disabilities.

K. Greiner, N. Nazir, T. Shireman, 2010, Disability and health journal.

A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias.

P. Moriarty, Brian J. Barnes, J. Backes, 2011, Atherosclerosis.

Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.

J. Luyendyk, C. Gibson, P. Moriarty, 2010, The American journal of cardiology.

Comparing patients' prescribed, self-reported, and actual intake of supplemental eicosapentaenoic acid + docosahexaenoic acid.

B. Melton, P. Moriarty, J. Backes, 2019, Journal of clinical lipidology.

Identifying patient perceptions and attitudes regarding statin-associated diabetes mellitus: a mixed-methods study.

Jaehoon Lee, C. Gibson, Rebecca R Mount, 2019, Future cardiology.

Effect of Lipid-Lowering Drug Therapy on Small-Dense Low-Density Lipoprotein

C. Gibson, J. Backes, 2005, The Annals of pharmacotherapy.

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

D. Hilleman, D. Anzalone, J. Backes, 2016, Lipids in Health and Disease.

Important Considerations for Treatment with Dietary Supplement versus Prescription Niacin Products

P. Moriarty, R. Padley, J. Backes, 2011, Postgraduate medicine.

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.

Jerome J. Schentag, J. Paladino, T. Cumbo, 1991, The American journal of medicine.

The effects of mipomersen, a secondgeneration antisense oligonucleotide, on atherogenic (apoB-containing) lipoproteins in the treatment of homozygous familial hypercholesterolemia

P. Moriarty, M. McGowan, J. Backes, 2014 .

Identifying pseudohypertriglyceridemia in clinical practice

T. Dayspring, J. Mcconnell, J. Contois, 2014 .

Optimal Lipid Modification: The Rationale for Combination Therapy

C. Gibson, P. Howard, J. Backes, 2005, Vascular health and risk management.

Role of C-Reactive Protein in Cardiovascular Disease

P. Moriarty, P. Howard, J. Backes, 2004, The Annals of pharmacotherapy.

Fibrates: What Have We Learned in the Past 40 Years?

C. Gibson, P. Moriarty, J. Backes, 2007, Pharmacotherapy.

Combination Drug Therapy: A Strategy for Aggressive Lipid Modification

P. Howard, J. Backes, 2005 .

Apple pectin for the reduction of niacin-induced flushing.

P. Moriarty, Jianghua He, J. Backes, 2013, Journal of clinical lipidology.

C-Reactive Protein as a Marker for Cardiovascular Disease

P. Howard, J. Backes, 2004 .

Association of HMG-CoA Reductase Inhibitors with Neuropathy

P. Howard, J. Backes, 2003, The Annals of pharmacotherapy.

Omega-3 Fatty Acids: Emerging Role for Cardioprotection

P. Howard, J. Backes, 2008 .

Statins and almonds to lower lipoproteins (the STALL Study).

Bryan K. Smith, P. Kris-Etherton, D. Sullivan, 2015, Journal of clinical lipidology.

Effectiveness and Tolerability of Every-Other-Day Rosuvastatin Dosing in Patients with Prior Statin Intolerance

P. Thompson, C. Gibson, P. Moriarty, 2008, The Annals of pharmacotherapy.

Does Simvastatin Cause More Myotoxicity Compared with Other Statins?

P. Moriarty, P. Howard, J. Backes, 2009, The Annals of pharmacotherapy.

Statin-Associated Diabetes Mellitus: Review and Clinical Guide

C. Gibson, J. Backes, Matthew D Kostoff, 2016, Southern medical journal.

A Comparison of Patients’ Prescribed, Self-Reported, and Actual Intake of Supplemental EPA/DHA

B. Melton, P. Moriarty, J. Backes, 2016 .

Supratherapeutic Response to Ezetimibe in a Statin Intolerant Patient

P. Moriarty, J. Backes, Janelle F. Ruisinger, 2010 .

Variability in Potency Among Commercial Preparations of Berberine

R. Singh, S. Kandel, R. Winefield, 2018, Journal of dietary supplements.

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

D. Hilleman, D. Anzalone, J. Backes, 2016, Lipids in Health and Disease.

Developing a Healthy Lifestyle Program for Recent Kidney Transplant Recipients

A. Naik, D. Sullivan, C. Gibson, 2023, Progress in transplantation.

Krill Oil for Cardiovascular Risk Prevention: Is it for Real?

P. Howard, J. Backes, 2014, Hospital pharmacy.